Is Anti-platelet Treatment Necessary for Penile Mondor’s Disease?

• Main Authors: Ahmet Murat Bayraktar, Muhammet İrfan Dönmez
• Format: Article
• Language: English
• Published: Galenos Yayinevi 2019-03-01
• Series: Journal of Urological Surgery
• Subjects: Penile; Mondor’s disease; Anti-platelet; Treatment
• Online Access: http://jurolsurgery.org/archives/archive-detail/article-preview/s-anti-platelet-treatment-necessary-for-penile-mon/25672

Objective:The aim of this study was to determine if anti-platelet treatment would have any effect on the rate and duration of resolution in penile Mondor’s disease.Materials and Methods:A retrospective review of patients diagnosed with Mondor’s disease between 2014 and 2018 was conducted. The patients were divided into two groups with regard to anti-platelet treatment. Age, initial symptom, medications [short-term fluoroquinolone antibiotics (Ab) ± low-dose acetyl salicylic acid (ASA)], and erectile function scores were evaluated. Moreover, ultrasonographic findings (location and length of thrombus) were noted.Results:A total of 14 patients were diagnosed with penile Mondor’s disease. The mean age of the patients was 36 years (range: 18-66). The initial symptom was penile induration in all patients. Thrombus was located distally in 3, mid penile in 5 and proximally in 6. The median length of thrombus was 20 mm (range: 10-50 mm). In 13 patients (92.8%), thrombus resolved and patients became symptom-free. The median time to resolution was 3 weeks (range: 2-7). Eight patients received Ab + ASA while 5 received Ab only. There was no statistically significant difference between the groups in terms of the rate and duration of resolution (p=1.00 and 0.55, respectively).Conclusion:Our results showed that anti-platelet treatment may be unnecessary for the treatment of penile Mondor’s disease.